NOW - ServiceNow, Inc.

NYSE - NYSE Delayed Price. Currency in USD
414.21
-2.58 (-0.62%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close416.79
Open421.31
Bid414.21 x 800
Ask413.99 x 1000
Day's Range412.69 - 424.84
52 Week Range213.99 - 424.84
Volume1,360,954
Avg. Volume2,086,101
Market Cap78.991B
Beta (5Y Monthly)1.35
PE Ratio (TTM)123.42
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-15% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Were Hedge Funds Right About Piling Into ServiceNow Inc (NOW)?
    Insider Monkey

    Were Hedge Funds Right About Piling Into ServiceNow Inc (NOW)?

    We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. We are almost done with the second quarter. Investors decided […]

  • Goldman Sachs: There’s an Opportunity Brewing in These 3 Stocks
    TipRanks

    Goldman Sachs: There’s an Opportunity Brewing in These 3 Stocks

    The COVID-19 pandemic has decimated the U.S. economy, yet the stock market is alive and well. Against the backdrop of a recession, the market actually had its strongest quarter in over 20 years, with the S&P 500 notching its largest quarterly gain since the last quarter of 1998, surging 20%. As for the NASDAQ, it climbed 31% higher during the quarter, marking its best quarterly performance since Q4 1999.While certainly volatile, the quarter saw investors take an optimistic approach due to reopening efforts and unprecedented stimulus packages. That being said, going forward into Q3, plenty of uncertainty is lingering over Wall Street. So, how are investors supposed to lock in on compelling plays? The Street’s pros can provide some much-needed inspiration, namely those from investment firm Goldman Sachs.Taking all of this into consideration, we used TipRanks’ database to learn more about three stocks backed by Goldman Sachs. As it turns out, the firm’s analysts projecting more than 30% upside potential for each. The rest of the Street is on the same page, with each ticker earning a “Strong Buy” consensus rating.Myovant Sciences (MYOV)Combining purpose-driven science, empowering medicines and transformative advocacy, Myovant Sciences wants to change the treatment landscape for both women and men. On the heels of its recent data readout, Goldman Sachs is even more optimistic about this healthcare name.Covering this stock for the firm, five-star analyst Paul Choi tells clients that a key component of his bullish thesis is its relugolix asset. MYOV recently published positive Phase 3 data from its SPIRIT 1 study evaluating a once-daily relugolix combination therapy in women with endometriosis. This data supported the data from the previously reported SPIRIT 2 study.Looking more closely at the results, 74.5% of patients saw a clinically meaningful reduction in dysmenorrhea compared to 26.9% of women in the placebo group, with the placebo-adjusted difference landing at 47.6%. Choi notes that Orilissa, the currently approved therapy for moderate to severe pain caused by endometriosis, demonstrated a 27%/21% (two trials) placebo-adjusted difference for its 150 mg once-daily therapy and a difference of 56%/50% for its 200 mg twice daily dose.However, Orilissa can cause hypoestrogenic symptoms including hot flashes and loss of bone mineral density. Choi pointed out, “To avoid this, physicians can co-prescribe progestin and/or estradiol (add-back therapy). However, physicians emphasized that the once-daily, fixed-dose pill containing relugolix and add-back therapy would more readily convince a physician to prescribe it instead as the dosing schedule of Orilissa can be confusing, even for the prescriber.” MYOV’s candidate produced significantly fewer hot flashes, making Choi even more confident.“In addition to the side effect profile and simple dosing schedule, physicians called out that many OBGYN offices were not equipped to handle the prior authorizations required for use. MYOV has focused efforts here to ensure that the proper tools are delivered to support prior auth requirements,” Choi added.As updated data from the Phase 3 open-label extension study (LIBERTY) evaluating relugolix combination therapy in women with uterine fibroids (UF) was also promising, the deal is sealed for Choi. To this end, the analyst maintained a Buy rating along with a $28 price target, suggesting 40% upside potential. (To watch Choi’s track record, click here)   Most other analysts also take a bullish approach. MYOV’s Strong Buy consensus rating breaks down into 3 Buys and only 1 Hold. Additionally, the $27.33 average price target puts the upside potential at 36%. (See MYOV stock analysis on TipRanks)Southwest Airlines (LUV)It’s no secret that COVID-19 has dealt the travel industry a swift blow. That being said, as passenger volumes have started to recover from the low point hit in April and market trends improve, Goldman Sachs is turning more bullish on Southwest Airlines.Representing the firm, analyst Catherine O’Brien doesn’t dispute the fact that since LUV was added to the Americas Sell List on February 19, shares have plummeted 40% compared to the S&P 500’s 8% loss.Singing a different tune now, O’Brien argues that given the airline industry’s focus on driving a rebound from the pandemic-induced lows, “Southwest’s primarily domestic network and industry leading balance sheet will drive a faster-than-industry recovery in profitability.”Specifically looking at the latter, the analyst commented, “Additionally, given that liquidity remains a concern for the industry, balance sheet strength is currently of even more importance than it typically is, in our view.”It should also be noted that LUV shares have historically experienced less turbulence than other players in the space. Therefore, while it boasts less upside potential than some of the firm’s other Buy-rated stocks, the level of upside here is enough to convince O’Brien to stand squarely in the bull camp.As a result, O’Brien just gave LUV a thumbs up, upgrading her rating from Sell to Buy. If that wasn’t enough, the price target also gets a lift, from $35 to $47. Should the target be met, a twelve-month gain of 37% could be in store. (To watch O’Brien’s track record, click here)  In general, other analysts also like what they’re seeing. 11 Buys and 3 Holds add up to a Strong Buy consensus rating. Based on the $42.25 average price target, the upside potential comes in at 23%. (See LUV stock analysis on TipRanks)ServiceNow (NOW)As for Goldman Sachs’ third pick, ServiceNow offers software that delivers digital workflows designed to improve productivity. Given the strength of its technology, the firm sees big things in store for the tech company.After looking at the space as a whole, four-star analyst Christopher Merwin goes so far as to deem NOW a best idea. Expounding on this, he wrote, “We believe the resiliency of the sector throughout COVID underscores the criticality of many software categories as businesses adjust for more distributed workforces and therefore require modernized cloud systems. With sector multiples at all-time highs, we favor stocks where we see compelling relative value.”According to Merwin, NOW is set to be a “key beneficiary of digital transformations as enterprise customers increasingly focus on leveraging a select few strategic platforms that can deliver could-based solutions with ease, agility, and integrations.” Citing its product development, the analyst believes its approach is “best-in-class", with the company continuing to expand into new areas like financial operations management and DevOps.“We believe this rich product roadmap, and ongoing momentum for ITSM, ITOM, HR, and CSM, will all help to sustain 28%-plus subscription revenue growth through FY22E,” Merwin commented. Going forward, its efforts to re-invest in new products in order to increase the addressable market and runway for growth should help NOW reach its long-term revenue target of $10 billion, in the analyst’s opinion.Merwin added, “As software valuations continue to move higher across the space, we believe NOW stands out as an attractively valued stock - particularly on a growth-adjusted FCF, trading at 45.5x our CY21E FCF, relative to FCF growth expectations of 35%.”It should come as no surprise, then, that Merwin stayed with the bulls. In addition to keeping a Buy rating on the stock, the analyst gave the price target a boost, from $403 to $538, which brings the upside potential to 33%. (To watch Merwin’s track record, click here) Do other analysts agree with Merwin? As it turns out, most do. With 19 Buys and 4 Holds assigned in the last three months, the word on the Street is that NOW is a Strong Buy. However, at $396.32, the average price target does indicate 3% downside potential. (See ServiceNow stock-price forecast on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

  • The Zacks Analyst Blog Highlights: Tesla, NVIDIA, ServiceNow, Vertex and Activision Blizzard
    Zacks

    The Zacks Analyst Blog Highlights: Tesla, NVIDIA, ServiceNow, Vertex and Activision Blizzard

    The Zacks Analyst Blog Highlights: Tesla, NVIDIA, ServiceNow, Vertex and Activision Blizzard

  • ServiceNow (NOW) to Acquire Sweagle to Enhance Now Platform
    Zacks

    ServiceNow (NOW) to Acquire Sweagle to Enhance Now Platform

    ServiceNow's (NOW) acquisition of Sweagle is expected boost customer experience through rapid deployment of applications and infrastructure as well as preventing process disruptions.

  • ServiceNow to acquire Belgian configuration management startup Sweagle
    TechCrunch

    ServiceNow to acquire Belgian configuration management startup Sweagle

    ServiceNow, which includes in its product catalog an IT Help Desk component, recognizes that help desks have been bombarded during the pandemic. To help stop configuration problems before they start, the company today acquired Sweagle, a configuration management startup based in Belgium. ServiceNow gets a couple of boosts in the deal.

  • 5 Tech Stocks to Buy as Second Wave of Coronavirus Haunts
    Zacks

    5 Tech Stocks to Buy as Second Wave of Coronavirus Haunts

    The United States has finally started reopening its economy but with that also comes the bad news of a surge in daily cases.

  • Thomson Reuters StreetEvents

    Edited Transcript of NOW.N earnings conference call or presentation 29-Apr-20 9:00pm GMT

    Q1 2020 ServiceNow Inc Earnings Call

  • The Zacks Analyst Blog Highlights: Everbridge, ServiceNow, Domo, UnitedHealth and Pegasystems
    Zacks

    The Zacks Analyst Blog Highlights: Everbridge, ServiceNow, Domo, UnitedHealth and Pegasystems

    The Zacks Analyst Blog Highlights: Everbridge, ServiceNow, Domo, UnitedHealth and Pegasystems

  • 4 Cloud-Focused Stocks to Buy Amid the Coronavirus Pandemic
    Zacks

    4 Cloud-Focused Stocks to Buy Amid the Coronavirus Pandemic

    With people now preferring to work remotely due to the growing number of cases of coronavirus, cloud stocks are been keenly watched by investors.

  • Dow Jones Futures Tumble: Stock Market Rally At Key Level As Coronavirus Cases Pick Up; Analyzing Nvidia, PayPal, Tesla Stock
    Investor's Business Daily

    Dow Jones Futures Tumble: Stock Market Rally At Key Level As Coronavirus Cases Pick Up; Analyzing Nvidia, PayPal, Tesla Stock

    Dow Jones futures signaled key tests for the stock market rally as coronavirus cases in the U.S. and China increase. Tesla, Nvidia, PayPal are in focus.

  • Investopedia

    ServiceNow Stock Could Fail May Breakout

    ServiceNow stock has made little progress since breaking out in early May and could lose ground into the third quarter.

  • Is ServiceNow (NOW) Stock Outpacing Its Computer and Technology Peers This Year?
    Zacks

    Is ServiceNow (NOW) Stock Outpacing Its Computer and Technology Peers This Year?

    Is (NOW) Outperforming Other Computer and Technology Stocks This Year?

  • The Zacks Analyst Blog Highlights: NVIDIA, Applied Materials, Apple, ServiceNow and Taiwan Semiconductor Manufacturing
    Zacks

    The Zacks Analyst Blog Highlights: NVIDIA, Applied Materials, Apple, ServiceNow and Taiwan Semiconductor Manufacturing

    The Zacks Analyst Blog Highlights: NVIDIA, Applied Materials, Apple, ServiceNow and Taiwan Semiconductor Manufacturing

  • GuruFocus.com

    Wednesday Morning Market Highlights

    Nasdaq rose to an all-time high, Five Below up on earnings report Continue reading...

  • 5 Must-Buy Tech Behemoths as Nasdaq Composite Touches 10,000
    Zacks

    5 Must-Buy Tech Behemoths as Nasdaq Composite Touches 10,000

    We have narrowed down our search to five tech stocks that have strong growth potential for 2020 and robust EPS estimate revisions.

  • ServiceNow (NOW) Gains As Market Dips: What You Should Know
    Zacks

    ServiceNow (NOW) Gains As Market Dips: What You Should Know

    ServiceNow (NOW) closed the most recent trading day at $388.83, moving +0.57% from the previous trading session.

  • Chief Market Strategist on why investors need to look at a company's balance sheet
    Yahoo Finance Video

    Chief Market Strategist on why investors need to look at a company's balance sheet

    Victoria Fernandez, Crossmark Global Investments Chief Market Strategist, joins The Final Round to discuss the recent market volatility and the NASDAQ tops 10,000 for the first time.

  • GuruFocus.com

    Tuesday Morning Market Highlights

    Nasdaq jumps to record high, Tiffany up on earnings report Continue reading...

  • GuruFocus.com

    Monday Morning Market Highlights

    U.S. stocks advance, Thor Industries jumps on earnings report Continue reading...

  • Dow Jones Futures Rise Amid Coronavirus Market Rally Rotation; Tesla China Sales Rebound
    Investor's Business Daily

    Dow Jones Futures Rise Amid Coronavirus Market Rally Rotation; Tesla China Sales Rebound

    The coronavirus market rally is at highs amid sector rotation: Here's what to do. Apple and Amazon are among eight diverse Leaderboard stocks in or near buy zones.

  • DELL vs. NOW: Which Stock Is the Better Value Option?
    Zacks

    DELL vs. NOW: Which Stock Is the Better Value Option?

    DELL vs. NOW: Which Stock Is the Better Value Option?

  • The Zacks Analyst Blog Highlights: Chegg, Tencent, GoDaddy, Fortinet and ServiceNow
    Zacks

    The Zacks Analyst Blog Highlights: Chegg, Tencent, GoDaddy, Fortinet and ServiceNow

    The Zacks Analyst Blog Highlights: Chegg, Tencent, GoDaddy, Fortinet and ServiceNow

  • Why ServiceNow Stock Gained 10.4% Last Month
    Motley Fool

    Why ServiceNow Stock Gained 10.4% Last Month

    The enterprise software company is crushing the market in 2020, and its stock is up roughly 250% over the last three years.